[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort].


Journal

Hinyokika kiyo. Acta urologica Japonica
ISSN: 0018-1994
Titre abrégé: Hinyokika Kiyo
Pays: Japan
ID NLM: 0421145

Informations de publication

Date de publication:
Nov 2019
Historique:
entrez: 7 1 2020
pubmed: 7 1 2020
medline: 24 1 2020
Statut: ppublish

Résumé

We evaluated the safety of laparoscopic radical cystectomy (LRC) during initial phases and its learning curve in a Japanese multicenter cohort by studying 436 patients who underwent LRC with no robot assistance at 10 institutions in Japan. We divided the patients into three groups according to cumulative surgical volume at each institution (first 10 cases, 11-30 cases, after 31 cases in each institution), and compared perioperative and pathologic variables among the three groups. The first, second, and third groups included 100, 166, 170 patients, respectively. The preoperative variables were similar in the three groups except for the rate of neoadjuvant chemotherapy. The methods of LRC procedure, such as urinary diversion, the extent of lymph node dissection, and concomitant urethrectomy or nephroureterectomy, were similar in the three groups. Mean operative time was 629, 562 and 531 minutes, respectively, and mean blood loss was 755, 650 and 435 ml, respectively. Both values decreased over time with the institution's experience. There was no significant difference among the three groups in the rate of positive surgical margin, the number of retrieved lymph nodes, and the rate of intra- and postoperative complications. LRC was safely performed during initial phases with an acceptable complication rate and without compromising oncological results, although operative time was longer and blood loss increased.

Identifiants

pubmed: 31902175
doi: 10.14989/ActaUrolJap_65_11_439
doi:

Types de publication

Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

439-444

Auteurs

Toru Kanno (T)

The Department of Urology, Ijinkai Takeda General Hospital.

Takahiro Inoue (T)

The Department of Urology, Graduate School of Medicine, Kyoto University.

Katsuhiro Ito (K)

The Department of Urology, Graduate School of Medicine, Kyoto University.

Yuka Kono (Y)

The Department of Urology, Tenri Hospital.

Hiroaki Kawanishi (H)

The Department of Urology, Tenri Hospital.

Kazuhiro Okumura (K)

The Department of Urology, Tenri Hospital.

Hitoshi Yamada (H)

The Department of Urology, Ijinkai Takeda General Hospital.

Masashi Kubota (M)

The Department of Urology, Kobe City Medical Center General Hospital.

Mutsushi Kawakita (M)

The Department of Urology, Kobe City Medical Center General Hospital.

Masato Fujii (M)

The Department of Urology, Miyazaki University.

Naoki Terada (N)

The Department of Urology, Miyazaki University.

Toshiyuki Kamoto (T)

The Department of Urology, Miyazaki University.

Yosuke Shimizu (Y)

The Department of Urology, Nishikobe Medical Center.

Noriyuki Ito (N)

The Department of Urology, Nishikobe Medical Center.

Kenichiro Tanoue (K)

The Department of Urology, Kumamoto University.

Tomomi Kamba (T)

The Department of Urology, Kumamoto University.

Go Kobori (G)

The Department of Urology, Hamamatsu Rosai Hospital.

Seiji Moroi (S)

The Department of Urology, Hamamatsu Rosai Hospital.

Akihiro Hamada (A)

The Department of Urology, Otsu Municipal Hospital.

Kimihiko Masui (K)

The Department of Urology, Otsu Municipal Hospital.

Yasumasa Shichiri (Y)

The Department of Urology, Otsu Municipal Hospital.

Noboru Shibasaki (N)

The Department of Urology, Rakuwakai Otowa Hospital.

Toshiya Akao (T)

The Department of Urology, Rakuwakai Otowa Hospital.

Atsuro Sawada (A)

The Department of Urology, Graduate School of Medicine, Kyoto University.

Ryoich Saito (R)

The Department of Urology, Graduate School of Medicine, Kyoto University.

Takashi Kobayashi (T)

The Department of Urology, Graduate School of Medicine, Kyoto University.

Osamu Ogawa (O)

The Department of Urology, Graduate School of Medicine, Kyoto University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH